Thyroid carcinoma in dogs.

What it is

Canine thyroid carcinoma arises from the thyroid follicular cells (or, less commonly, the C-cells producing calcitonin). Unlike cats, where thyroid masses are usually benign hyperplasia or adenomas, the vast majority of canine thyroid masses palpable in the cervical region turn out to be carcinomas.

Most affected dogs are euthyroid (normal thyroid hormone levels); a smaller subset are hyperthyroid or hypothyroid at diagnosis. The clinical picture is usually about the local mass and its complications rather than hormone abnormalities.

Signs to watch for

• A firm, sometimes mobile mass in the throat region below the larynx — often noticed during petting or grooming.
• Coughing, change in bark, or labored breathing if the tumor compresses the trachea.
• Difficulty swallowing if it impinges on the esophagus.
• Pre-scapular lymph node enlargement in some cases of regional spread.

How veterinarians diagnose it

FNA of a thyroid mass can yield diagnostic cytology but carries some risk of hemorrhage given the tumor's vascular nature — ultrasound guidance is preferred.

Imaging — neck ultrasound to assess size, invasiveness, and mobility (a key determinant of surgical feasibility), and CT for surgical planning if resection is considered. Chest radiographs or CT staging for lung metastasis are essential because metastatic spread is common at diagnosis.

Thyroid function testing (T4, free T4, TSH) helps identify the small minority of dogs who are functionally hyper- or hypothyroid.

What treatment usually looks like

• Surgical excision (thyroidectomy) is the treatment of choice for tumors that are well-circumscribed and movable — these tend to be smaller and not yet invading surrounding tissues. Outcomes for surgically resectable disease can be excellent.
• Radiation therapy as definitive treatment for tumors fixed to surrounding tissue and not surgically resectable. Effective local control in many cases.
• Radioactive iodine (I-131) is available at a small number of specialized centers and can be effective, particularly for hyperthyroid carcinomas or metastatic disease.
• Chemotherapy (doxorubicin or carboplatin) is sometimes used adjunctively, particularly for larger or metastatic tumors, though benefit is modest.
• Toceranib (Palladia) has shown activity in some canine thyroid carcinomas.

Prognosis

Surgically resectable freely-mobile tumors carry the best prognosis — published median survival can be measured in years for some cases.

Fixed, invasive, or metastatic tumors have shorter median survival even with treatment, though many dogs can be helped substantially with radiation and/or systemic therapy.

Questions to ask your vet

• Is the mass freely mobile or fixed to surrounding tissue?
• Has the chest been imaged for metastasis?
• Is surgery feasible at our clinic, or do we need a referral surgeon?
• If surgery isn't feasible, is radiation available within reach?
• Has my dog's thyroid function been tested? Does it affect the plan?

Where to learn more

Veterinary teaching hospitals at most accredited US vet schools maintain owner-facing fact sheets on common cancers. Peer-reviewed journals — JAVMA, Veterinary and Comparative Oncology, Frontiers in Veterinary Science — are accessible through PubMed. The American College of Veterinary Internal Medicine (ACVIM) and the Veterinary Cancer Society publish consensus statements you can ask your vet to walk you through.

For clinical trials enrolling dogs with this diagnosis, see the SciRouter Vet trial finder — we index AVMA, NCI COTC, and twelve university registries.